Danone has released its new probiotic supplement, Almimama, to reduce the incidence of mastitis
Danone has used its expertise in breastmilk research and breastfeeding to develop Almimama, a probiotic supplement that can help reduce the incidence of mastitis. Affecting approximately one in four mothers, mastitis (inflammation in the breast) causes flu-like symptoms and breast pain, as well as skin rashes, fever and breast engorgement.
Breastmilk is widely recognised as nature’s most powerful nutrition and tailormade for a baby’s needs, providing many short- and long-term benefits for both babies and mothers. Despite these benefits, only 48% of babies under six months of age are exclusively breastfed. Research has shown complications like mastitis are one of the key barriers to continue breastfeeding.
Almimama is the only synbiotic supplement for pregnant or lactating mothers that combines the probiotic strain L. salivarius PS2 with fructo-oligosaccharides (FOS)
Research has also shown probiotic supplementation during late pregnancy and in the early stages of breastfeeding reduces the incidence of mastitis. Probiotics or ‘’good bacteria’’ are live microorganisms that, when administered in adequate amounts, bring a health benefit to the people consuming them.
Almimama is the only synbiotic supplement for pregnant or lactating mothers that combines the probiotic strain L. salivarius PS2 with fructo-oligosaccharides (FOS).
A recent study found that taking probiotics with this specific probiotic strain can significantly reduce the incidence of mastitis by up to 59% compared to placebo if taken during pregnancy. Because mastitis is considered one of the main reasons mothers stop breastfeeding, Almimama has the potential to support or extend the duration of breastfeeding. It is recommended to be taken in the third trimester of pregnancy and during breastfeeding.
“Many women say during pregnancy they used to imagine what it would be like to give birth, but they never, or rarely, consider not being able to breastfeed. They are given little information in this regard and may not know that complications occur in up to one-third of cases. We understand this can be distressing and, with this solution, we hope to support mothers in extending their breastfeeding journey as long as possible,” said Rocio Martin, Global Medical and Scientific Affairs Director at Danone.
Danone is committed to supporting parents in all feeding journeys. With the launch of Almimama in Spain, it concretely reinforces its support of the journey of breastfeeding mothers. Almimama is provided in packs of 30 powdered sachets, to be taken once a day as per the recommended dose. The supplement has a neutral taste and dissolves quickly in water. Each pack features a special QR code linking to online content about breastfeeding and its benefits.